Memorial Sloan Kettering Cancer Center
2019 ASH Review on Overcoming BTKi Resistance in CLL: Era of Non-Covalent BTKis? Role of Cellular Therapies
By
Cleveland Clinic's 20th Annual ASH Review
FEATURING
Anthony R. Mato
By
Cleveland Clinic's 20th Annual ASH Review
FEATURING
Anthony R. Mato
Login to view comments.
Click here to Login